Skip to main content
Krakchemia S.A. logo

Krakchemia S.A. — Investor Relations & Filings

Ticker · KCH ISIN · PLKRKCH00019 LEI · 259400QGYEAGRYCQ5Y56 WAR Wholesale and retail trade
Open in API
Filings indexed 587 across all filing types
Latest filing 2024-07-02 Director's Dealing
Country PL Poland
Listing WAR KCH

About Krakchemia S.A.

https://www.krakchemia.pl/en

Krakchemia S.A. is a distributor specializing in the wholesale trade of chemical products and plastics. The company's core offerings include a wide range of plastic raw materials, such as granules, and various types of packaging films. Its product portfolio also encompasses laboratory chemicals, reagents, and other chemical raw materials for industrial and commercial applications. The company provides value-added services, including the slitting and rewinding of films, utilizing modern machinery for materials intended for food contact.

Recent filings

Filing Released Lang Actions
Powiadomienie o transakcji o której mowa w art.19 ust.1 Rozporządzenia MAR - Content (PL)
Director's Dealing Classification · 100% confidence The document text is very short (436 characters) and explicitly states that it is reporting a transaction notification received on July 2, 2024, concerning an individual who is the Chairman of the Supervisory Board (a person discharging managerial responsibilities). It explicitly mentions Article 19(1) of the MAR Regulation and states that the notification itself is attached ('Zawiadomienie stanowi Załącznik do niniejszego raportu'). This structure—a brief announcement stating that the actual insider transaction report is attached or included—strongly indicates a Director's Dealing announcement, which is covered by the 'DIRS' code. Although it is a very short announcement, the specific subject matter (insider transaction under MAR Art. 19) overrides the general 'RPA' rule, as 'DIRS' is a more specific category for this content type.
2024-07-02 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zgromadzeniu KRAKCHEMIA S.A. w dniu 18 czerwca 2024 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text explicitly states it is providing a 'wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym Zgromadzeniu' (list of shareholders holding at least 5% of the votes at the Annual General Meeting) held on June 18, 2024. This content directly relates to the results of a shareholder vote at a general meeting, detailing the percentage of votes held by specific individuals during that meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is short and contains the core results, not an announcement about a separate report.
2024-06-19 Polish
Wykaz uchwał podjętych na ZWZA w dniu 18.06.2024 r.
AGM Information Classification · 100% confidence The document text is titled 'WYKAZ UCHWAŁ PODJĘTYCH NA ZWYCZAJNYM WALNYM ZGROMADZENIU AKCJONARIUSZY' (List of Resolutions Adopted at the Annual General Meeting) and details numerous resolutions (UCHWAŁA nr 1 through 16) passed by the 'Zwyczajne Walne Zgromadzenie' (Ordinary General Meeting) of KRAKCHEMIA S.A. on June 18, 2024. These resolutions cover the approval of the 2023 financial statements, management reports, and the granting of discharge (absolutorium) to board members. This content directly corresponds to the materials presented and voted upon during an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-06-18 Polish
Uchwały podjęte na Zwyczajnym Walnym Zgromadzeniu Akcjonariuszy KRAKCHEMIA S.A. w dniu 18.06.2024 roku. - Content (PL)
AGM Information Classification · 99% confidence The document text is very short (280 characters) and explicitly states that the Management Board (Zarząd) of KRAKCHEMIA S.A. informs that the Annual General Meeting (Zwyczajne Walne Zgromadzenie Akcjonariuszy) held on 18.06.2024 adopted resolutions indicated in Attachment No. 1 to the Report. This structure—a brief announcement referencing resolutions passed at an AGM and citing legal basis (Art. 56 Ustawy o ofercie)—is characteristic of reporting the outcome of a shareholder meeting. Since it is reporting the results of the vote/resolutions from the AGM, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). It is not the AGM presentation itself (AGM-R) nor a general regulatory filing (RNS), but a specific declaration of results.
2024-06-18 Polish
Podpisanie Aneksu do Umowy ubezpieczenia z COMPAGNIE FRANCAISE D'ASSURANCE POUR LE COMMERCE EXTERIEUR (COFACE) - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (850 characters) from KRAKCHEMIA S.A. informing the public that they received a signed Annex (Aneks) extending a Trade Credit Insurance Agreement (Umowy ubezpieczenia kredytu kupieckiego Tradeliner) with COFACE until June 30, 2026. It references previous reports and cites Article 17(1) of MAR (Market Abuse Regulation), indicating it is a mandatory disclosure of inside information. Since this is a specific announcement regarding a change in a financial agreement (insurance extension) and not a full financial report (like 10-K or IR), nor a general regulatory filing (RNS), it best fits the category for updates on financing or material contractual changes. Given the options, 'Capital/Financing Update' (CAP) is the closest fit as it relates to risk mitigation and financial arrangements, although 'Regulatory Filings' (RNS) is also plausible for MAR disclosures. However, because it details a specific material contract change affecting financial risk, CAP is slightly more precise than the general RNS fallback, though it is not a direct capital raise. Given the nature of the disclosure (material contract amendment affecting credit risk), and the short length suggesting an announcement rather than the full contract details, I will classify it as a specific material event disclosure. Since there isn't a perfect 'Material Contract Change' category, and it's not a standard ER, IR, or 10-K, I will default to the most appropriate specific category or the fallback. Since it is a material disclosure under MAR, and it concerns the terms of a significant financial protection instrument, I will lean towards RNS as the most accurate general regulatory disclosure category for MAR announcements that don't fit elsewhere, or CAP if interpreted broadly as a financing/risk management update. Given the options, RNS (Regulatory Filings) is the safest classification for a MAR-mandated disclosure of this nature that isn't a standard financial report or management change.
2024-05-24 Polish
Sprawozdanie finansowe za I kwartał 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ŚRÓDROCZNE SKRÓCONE SPRAWOZDANIE FINANSOWE ZA I KWARTAŁ 2024 ROKU' (Interim Condensed Financial Report for Q1 2024) for Krakchemia S.A. It contains detailed financial statements, including the Income Statement (Rachunek Zysków i Strat) and Balance Sheet (Bilans), along with notes and disclosures. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-23 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.